1-10 of 10
Christine M. Mcmahon
Close
Sort by
Articles

Targeting the Natural History of Clonal Hematopoiesis

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.2024414
Published: 2024
Articles

Targeting Telomerase in Lower-risk Myelodysplastic Syndromes

Christine M. Mcmahon, MD
Journal: The Hematologist
The Hematologist (2024) 21 (2)
https://doi.org/10.1182/hem.V21.2.2024218
Published: 2024
Articles

COMMANDing Anemia in Lower-risk Myelodysplastic Syndromes: Luspatercept Versus Erythropoiesis-stimulating Agents

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202364
Published: 2023
Articles

MEN1 Mutations Induce Acquired Resistance to the Menin Inhibitor Revumenib

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2023) 20 (5)
https://doi.org/10.1182/hem.V20.5.2023510
Published: 2023
Articles

Gene Therapy for Germline Predisposition to Myeloid Malignancies: Insights from a Nonhuman Primate RUNX1 Model

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2023) 20 (3)
https://doi.org/10.1182/hem.V20.3.2023313
Published: 2023
Articles

Not Just Caused by Getting Old: Germ Line Predisposition Identified in Patients of All Ages with Myelodysplastic Syndrome

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2023) 20 (2)
https://doi.org/10.1182/hem.V20.2.2023210
Published: 2023
Articles

Menin Inhibitors: A Promising Class of Targeted Therapies for KMT2A -rearranged and NPM1 -mutated Acute Leukemias

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.2022513
Published: 2022
Articles

Targeting AML in Unfit Patients: Ivosidenib/Azacitidine for IDH1 -mutated AML

Alexander G. Hayden, MD, Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2022) 19 (4)
https://doi.org/10.1182/hem.V19.4.202242
Published: 2022
Articles

Toward Understanding Disparities in AML Outcomes: The Role of Structural Racism

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2022) 19 (3)
https://doi.org/10.1182/hem.V19.3.202239
Published: 2022
Articles

STAMPing on BCR-ABL1: Asciminib Approved for Chronic Myeloid Leukemia

Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2022) 19 (2)
https://doi.org/10.1182/hem.V19.2.202221
Published: 2022